Post-Pandemic, Many U.S. Frontline Workers Plan To Keep Up Habits That Help Protect From Infection

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

February 5, 2021

Post-Pandemic: With the recent authorization and phased distribution of two COVID-19 vaccines, there are early indications that an end to our current global health crisis is in our sights.

Dr. Anthony Fauci, the government’s top infectious disease doctor, said in December 2020 that if the vaccine rollout goes well, the United States could approach herd immunity by the end of Summer 2021 and “normality that is close to where we were before” by the end of the year.

With an end to the pandemic within reach, we’re all looking ahead to what life post-Covid may look and feel like, and asking: to what extent will we, after months of social distancing, mask-wearing, hand-washing, and swabbing with nasal antiseptics — revert back to our old selves?

The answer, for some, rests in how exposed we may be to infection-causing germs in our daily lives. For those on the frontlines of the global health crisis, this risk of exposure will not completely go away once vaccinated. And, because healthcare workers will continue to be exposed to immunocompromised populations post-pandemic, they will need to continue to protect themselves from germs that cause respiratory infection.

New Jersey-based Certified Home Health Aide Victoria Gallucci received her first vaccine dose in January 2021. She understands the importance of adding layers of protection to her routine and has no intention of changing her routine once the current health crisis starts to subside. “As an in-home healthcare worker, I am providing direct care to my elderly patients every day. So, I need to be sure I’m doing everything I can to keep myself, and my clients, safe from infection,” Gallucci states.

“Even after receiving both my vaccine doses, I intend to keep up with my daily routine of protecting myself from infection. This includes wearing a mask, frequently washing and sanitizing my hands, and swabbing with a nasal antiseptic before leaving for work each day. These are essential layers of protection for me now,” she adds.

Among both essential workers and everyday Americans, nasal antiseptics are becoming increasingly more mainstream in providing next-level protection, as the nose is a main gateway for germs that lead to respiratory infection.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.